Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes

OBJECTIVE: The study objective was to investigate the protective effects of dexrazoxane (DRZ) on the cardiac autonomic nervous system (ANS) activity in anthracycline-treated breast cancer patients with diabetes. METHODS: A total of 110 early stage breast cancer patients with type 2 diabetes were div...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Fangyi, Shi, Jing, Geng, Cuizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591121/
https://www.ncbi.nlm.nih.gov/pubmed/27858873
http://dx.doi.org/10.1097/MD.0000000000005228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591121/
https://www.ncbi.nlm.nih.gov/pubmed/27858873
http://dx.doi.org/10.1097/MD.0000000000005228

Ejemplares similares